SCAP and metabolic disease: A recent study by Huang et al. [76] pointed to the potential role of macrophage sterol regulatory element binding protein (SREBP) cleavage-activating protein (SCAP) in amplifying the inflammatory response in adipose and liver tissues, leading to metabolic disorders participating in the development of lean NAFLD with metabolic changes.